Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Brucella suis biovar 1 (strain 1330) | Histidinol dehydrogenase | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Mycobacterium leprae | Probable histidinol dehydrogenase HisD (HDH) | Get druggable targets OG5_129099 | All targets in OG5_129099 |
Mycobacterium ulcerans | histidinol dehydrogenase | Get druggable targets OG5_129099 | All targets in OG5_129099 |
Candida albicans | Phosphoribosyl-AMP cyclohydrolase | Get druggable targets OG5_129099 | All targets in OG5_129099 |
Mycobacterium tuberculosis | Probable histidinol dehydrogenase HisD (HDH) | Get druggable targets OG5_129099 | All targets in OG5_129099 |
Candida albicans | Phosphoribosyl-AMP cyclohydrolase | Get druggable targets OG5_129099 | All targets in OG5_129099 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | TK/FER protein kinase | 0.0059 | 0 | 0.5 |
Echinococcus multilocularis | tyrosine protein kinase shark | 0.1995 | 1 | 1 |
Mycobacterium tuberculosis | Probable histidinol dehydrogenase HisD (HDH) | 0.0876 | 0.4224 | 0.5 |
Mycobacterium ulcerans | histidinol dehydrogenase | 0.0876 | 0.4224 | 0.5 |
Onchocerca volvulus | 0.0059 | 0 | 0.5 | |
Brugia malayi | SH2 domain containing protein | 0.0059 | 0 | 0.5 |
Brugia malayi | Protein kinase domain containing protein | 0.0059 | 0 | 0.5 |
Loa Loa (eye worm) | TK/FER protein kinase | 0.0059 | 0 | 0.5 |
Onchocerca volvulus | 0.0059 | 0 | 0.5 | |
Brugia malayi | protein-tyrosine kinase | 0.0059 | 0 | 0.5 |
Loa Loa (eye worm) | TK/ABL protein kinase | 0.0059 | 0 | 0.5 |
Loa Loa (eye worm) | TK/FER protein kinase | 0.0059 | 0 | 0.5 |
Onchocerca volvulus | 0.0059 | 0 | 0.5 | |
Loa Loa (eye worm) | TK protein kinase | 0.0059 | 0 | 0.5 |
Mycobacterium leprae | Probable histidinol dehydrogenase HisD (HDH) | 0.0876 | 0.4224 | 0.5 |
Schistosoma mansoni | tyrosine kinase | 0.1949 | 0.9764 | 0.9764 |
Brugia malayi | hypothetical protein | 0.0059 | 0 | 0.5 |
Loa Loa (eye worm) | TK/FER protein kinase | 0.0059 | 0 | 0.5 |
Brugia malayi | Tyrosine-protein kinase abl-1 | 0.0059 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0059 | 0 | 0.5 |
Brugia malayi | Protein kinase domain containing protein | 0.0059 | 0 | 0.5 |
Brugia malayi | Protein kinase domain containing protein | 0.0059 | 0 | 0.5 |
Schistosoma mansoni | tyrosine kinase | 0.1995 | 1 | 1 |
Onchocerca volvulus | 0.0059 | 0 | 0.5 | |
Brugia malayi | Protein kinase domain containing protein | 0.0059 | 0 | 0.5 |
Loa Loa (eye worm) | TK/FER protein kinase | 0.0059 | 0 | 0.5 |
Onchocerca volvulus | 0.0059 | 0 | 0.5 | |
Brugia malayi | SRC-1 | 0.0059 | 0 | 0.5 |
Loa Loa (eye worm) | TK/FER protein kinase | 0.0059 | 0 | 0.5 |
Loa Loa (eye worm) | TK/FER protein kinase | 0.0059 | 0 | 0.5 |
Brugia malayi | SH2 domain containing protein | 0.0059 | 0 | 0.5 |
Entamoeba histolytica | SH2-protein kinase domain containing protein | 0.0059 | 0 | 0.5 |
Onchocerca volvulus | 0.0059 | 0 | 0.5 | |
Brugia malayi | Protein kinase domain containing protein | 0.0059 | 0 | 0.5 |
Loa Loa (eye worm) | SRC-1 | 0.0059 | 0 | 0.5 |
Loa Loa (eye worm) | TK/FER protein kinase | 0.0059 | 0 | 0.5 |
Loa Loa (eye worm) | TK/FER protein kinase | 0.0059 | 0 | 0.5 |
Loa Loa (eye worm) | TK/FER protein kinase | 0.0059 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 19.23 uM | Inhibition of Brucella suis 1330 His6-tagged HDH expressed in Escherichia coli BL21 (DE3) using L-histidinol as substrate assessed as NADH formation preincubated for 5 mins followed by substrate addition | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.